[3β(2R,3R),4α,6α,7α,15α(R),16β]-4,9-Epoxycevan-3,4,6,7,14,15,16,20-octol-6,7-diacetat-3-(2,3-dihydroxy-2-methylbutyrat)-15-(2-methylbutyrat)
Bezeichnung:[3β(2R,3R),4α,6α,7α,15α(R),16β]-4,9-Epoxycevan-3,4,6,7,14,15,16,20-octol-6,7-diacetat-3-(2,3-dihydroxy-2-methylbutyrat)-15-(2-methylbutyrat)
CAS-Nr124-97-0
Englisch Name:PROTOVERATRINE B
CBNumberCB0376499
SummenformelC41H63NO15
Molgewicht809.94
MOL-Datei124-97-0.mol
Synonyma
[3β(2R,3R),4α,6α,7α,15α(R),16β]-4,9-Epoxycevan-3,4,6,7,14,15,16,20-octol-6,7-diacetat-3-(2,3-dihydroxy-2-methylbutyrat)-15-(2-methylbutyrat)
[3β(2R,3R),4α,6α,7α,15α(R),16β]-4,9-Epoxycevan-3,4,6,7,14,15,16,20-octol-6,7-diacetat-3-(2,3-dihydroxy-2-methylbutyrat)-15-(2-methylbutyrat) physikalisch-chemischer Eigenschaften
| Schmelzpunkt | 268-270°C |
| alpha | D25 -37° (pyridine); D25 -3.5° (chloroform) |
| Siedepunkt | 755.18°C (rough estimate) |
| Dichte | 1.1826 (rough estimate) |
| Brechungsindex | 1.6220 (estimate) |
| storage temp. | 2-8°C |
| Löslichkeit | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. |
| Aggregatzustand | Powder |
| pka | 10.73±0.70(Predicted) |
| S-Sätze: | 22-24/25 |
| RIDADR | 1544 |
| WGK Germany | 3 |
| RTECS-Nr. | FL5750000 |
| HazardClass | 6.1(a) |
| PackingGroup | II |
| Toxizität | LD50 s.c. in male mice: 0.21 mg/kg (Tanaka) |